The story of monoclonal antibodies is a testament to the transformative power of scientific innovation combined with strategic business decisions. Monoclonal antibodies (mAbs) are lab-made proteins ...

The leading Chronic Urticaria Companies such as Synermore Biologics, Incyte Corporation, Jasper Therapeutics, Novartis, ...

Monoclonal antibodies (mAbs) offer promise as effective tumor targeting and drug delivery agents for cancer therapy. However, comparative biological and clinical characteristics of mAbs targeting the ...

Nipocalimab's FDA approval revolutionizes generalized myasthenia gravis treatment, offering rapid symptom relief and improved ...

Acquisition adds Phase 2 ready novel VISTA inhibiting monoclonal antibody (mAb) to TuHURA's late-stage immuno-oncology pipeline TuHURA planning to initiate a Phase ...

Acquisition adds Phase 2 ready novel VISTA inhibiting monoclonal antibody (mAb) to TuHURA's late-stage immuno-oncology pipeline TuHURA planning to ...

Felzartamab's mechanism of action designed to deplete the cells that produce ... About Felzartamab Felzartamab is an investigational therapeutic human monoclonal antibody directed against CD38, a ...

Global Phase 3 PROMINENT study will evaluate the efficacy and safety of felzartamab, as compared to tacrolimus, in adults ...

Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...

During early drug development and preclinical development, researchers use in vitro cultured lymphocytes to induce cytokine ...

Calico will leverage 9MW3811’s anti-inflammatory mechanism to advance its mission of addressing aging-related diseases.

Percheron Therapeutics (ASX: PER) has secured a worldwide exclusive licence from Singapore-based Hummingbird Bioscience for ...